当前位置： SCI文献检索 > International Journal of Clinical Oncology期刊下所有文献 > Screening rate for hepatitis B virus infection in patients undergoing chemotherapy in Japan.

Screening rate for hepatitis B virus infection in patients undergoing chemotherapy in Japan.

Abstract：

BACKGROUND:The aim of this study was to investigate the screening rate for hepatitis B virus (HBV) infection, which is recommended by some guidelines for the prevention of HBV reactivation, in patients undergoing chemotherapy for malignancy in Japan. METHODS:The study subjects were 3302 patients who had received first-line chemotherapy for malignancy from Apr 2008 through Mar 2013 utilizing the Claims Database of the Japan Medical Data Center. The proportion of patients who had been tested for HBsAg (P-HBsAg) and the proportion of HBsAg-negative patients who had undergone tests for anti-HBc and anti-HBs (P-HBc/HBsAb) before chemotherapy were investigated. RESULTS:P-HBsAg and P-HBc/HBsAb in all 3302 patients were 66.3 and 19.9 %, respectively. P-HBsAg in patients with solid tumors and those with hematological malignancies were 66.1 and 67.5 % (p = 0.61), respectively, and P-HBc/HBsAb were 12.3 and 75.8 % (p < 0.0001), respectively. P-HBsAg in patients from cancer centers and non-cancer centers were 66.9 and 65.5 % (p = 0.43), respectively, and P-HBc/HBsAb were 25.1 and 12.4 % (p < 0.0001), respectively. P-HBsAg in patients encountered before and after the announcement of the Japanese guideline were 51.3 and 67.1 % (p < 0.001), respectively, and P-HBc/HBsAb were 7.9 and 20.4 % (p = 0.01), respectively. CONCLUSIONS:The screening rate for HBV among cancer patients scheduled for chemotherapy remains unsatisfactory, especially in patients with solid tumors and those from non-cancer centers. Although the figures are improving after the announcement of the Japanese guideline, intensive measures to improve awareness about HBV reactivation during/after chemotherapy are needed.

journal_name

Int J Clin Oncol

journal_title

International journal of clinical oncology

authors

Ikeda M,Yamamoto H,Kaneko M,Oshima H,Takahashi H,Umemoto K,Watanabe K,Hashimoto Y,Ohno I,Mitsunaga S,Okusaka T

doi

10.1007/s10147-016-0995-8

subject

Has Abstract

pub_date

2016-12-01 00:00:00

pages

1162-1166

issue

6

eissn

1341-9625

issn

1437-7772

pii

10.1007/s10147-016-0995-8

journal_volume

21

pub_type

杂志文章

相关文献

International Journal of Clinical Oncology文献大全
  • Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.

    abstract：BACKGROUND:Six months of adjuvant chemotherapy is regarded as the standard of care for patients with stage III colon cancer. However, whether longer treatment can improve prognosis has not been fully investigated. We conducted a phase III study comparing 6 and 12 months of adjuvant capecitabine chemotherapy for stage I...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章,随机对照试验

    doi：10.1007/s10147-016-1083-9

    authors： Suto T,Ishiguro M,Hamada C,Kunieda K,Masuko H,Kondo K,Ishida H,Nishimura G,Sasaki K,Morita T,Hazama S,Maeda K,Mishima H,Ike H,Sadahiro S,Sugihara K,Okajima M,Saji S,Sakamoto J,Tomita N

    更新日期：2017-06-01 00:00:00

  • Salvage chemotherapy for recurrent or persistent clear cell carcinoma of the ovary: a single-institution experience for a series of 20 patients.

    abstract：BACKGROUND:Recurrent or persistent clear cell carcinoma (CCC) of the ovary is particularly chemotherapy resistant. The purpose of this study was to review our extensive institutional experiences with recurrent or persistent CCC with the aim of finding a more effective chemotherapy regimen. METHODS:The medical records ...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-011-0357-5

    authors： Yoshino K,Enomoto T,Fujita M,Ueda Y,Kimura T,Kobayashi E,Tsutsui T,Kimura T

    更新日期：2013-02-01 00:00:00

  • Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.

    abstract：:The updated 2016 World Health Organization (WHO) Classification of Tumours of the Central Nervous System (CNS) has incorporated molecular parameters into pathological diagnosis, for the first time in the molecular era. While it has led to the more precise diagnoses of well-understood entities and the better comprehens...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章,评审

    doi：10.1007/s10147-020-01695-w

    authors： Onizuka H,Masui K,Komori T

    更新日期：2020-06-01 00:00:00

  • "In situ preparation": new surgical procedure indicated for soft-tissue sarcoma of a lower limb in close proximity to major neurovascular structures.

    abstract：BACKGROUND:When soft-tissue sarcomas occur near neurovascular structures, preoperative images cannot always reveal the accurate relationship between the tumor and these structures. Therefore, in some patients, neurovascular structures are sacrificed unnecessarily. In other patients, neurovascular structures are preserv...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s101470200006

    authors： Matsumoto S,Kawaguchi N,Manabe J,Matsushita Y

    更新日期：2002-02-01 00:00:00

  • Malignant change secondary to fibrous dysplasia.

    abstract：BACKGROUND:Malignant change in fibrous dysplasia (FD) is very rare. This study was carried out to establish some characteristic clinical information about this disorder. METHODS:Four cases with a malignant change in FD out of 128 cases with FD were surgically treated and followed up for a median period of 61.3 months....

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-006-0559-4

    authors： Hoshi M,Matsumoto S,Manabe J,Tanizawa T,Shigemitsu T,Izawa N,Takeuchi K,Kawaguchi N

    更新日期：2006-06-01 00:00:00

  • A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1.

    abstract：:We report the case of a 62-year-old man with advanced gastric cancer and multiple liver metastases who was successfully treated with combined chemotherapy including S-1. The patient was clinically diagnosed with stage IV (T3 N2 H1 P0) disease and was initially treated with 100 mg/body per day S-1 administered orally f...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-006-0648-4

    authors： Nakamura R,Saikawa Y,Kumagai K,Kiyota T,Ohashi M,Yoshida M,Kubota T,Kumai K,Kitajima M

    更新日期：2007-08-01 00:00:00

  • Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?

    abstract：BACKGROUND:This study searched for extra capsular tumour spread (ECS) as a prognostic factor for recurrence in terms of Disease Free Survival (DFS) and Overall Survival (OS). PATIENTS AND METHODS:For this study, from a retrospective database of the Doubs cancer registry, 823 eligible women with node positive breast ca...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-012-0439-z

    authors： Dobi E,Bazan F,Dufresne A,Demarchi M,Villanueva C,Chaigneau L,Montcuquet P,Ivanaj A,Sautière JL,Maisonnette-Escot Y,Cals L,Algros MP,Woronoff AS,Pivot X

    更新日期：2013-08-01 00:00:00

  • Predicting short-term life expectancy of patients with end-stage gastric cancer using Onodera's prognostic nutritional index.

    abstract：BACKGROUND:Although the Onodera's prognosis nutritional index (O-PNI) has been used to predict long-term life expectancy, its use to predict life expectancy within 12 weeks has not been discussed. In this study, we examined the usefulness of the O-PNI to predict short-term life expectancy in patients with end-stage gas...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-020-01808-5

    authors： Oyama K,Oba M,Oshima Y,Shimada H

    更新日期：2021-02-01 00:00:00

  • Disease control and clinicopathological prognostic factors of total pharyngolaryngectomy for hypopharyngeal cancer: a single-center study.

    abstract：BACKGROUND:Total pharyngolaryngectomy (TPL) is a conventional and standard surgical method for locoregional control of advanced hypopharyngeal cancer (HPC). This study aimed to define the clinicopathological prognostic factors of TPL by evaluating our surgical experience of TPL in the treatment of HPCs. METHODS:We ret...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-014-0709-z

    authors： Omura G,Ando M,Saito Y,Kobayashi K,Yamasoba T,Asakage T

    更新日期：2015-04-01 00:00:00

  • Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer.

    abstract：BACKGROUND:We aimed to determine the safety and efficacy of monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer (HRPC). METHODS:Patients with prostate cancer that was progressing despite androgen ablation therapy were treated with i.v. paclitaxel, 175...

    journal_title：International journal of clinical oncology

    pub_type： 临床试验,杂志文章

    doi：10.1007/s10147-005-0513-x

    authors： Segawa T,Kamoto T,Kinoshita H,Kunishima Y,Yoshimura K,Ito A,Takahashi T,Higashi S,Nakamura E,Nishiyama H,Ito N,Yamamoto S,Habuchi T,Ogawa O

    更新日期：2005-10-01 00:00:00

  • Long-term influence of adjuvant breast radiotherapy on cognitive function in breast cancer patients treated with conservation therapy.

    abstract：BACKGROUND:The mechanisms underlying cognitive decline after radiotherapy not directed at brain areas remains unclear. We previously suggested that adjuvant breast radiotherapy in breast conservation therapy could lower memory function soon after therapy, and that the process might be partially mediated by plasma inter...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-018-1330-3

    authors： Shibayama O,Yoshiuchi K,Inagaki M,Matsuoka Y,Yoshikawa E,Sugawara Y,Akechi T,Wada N,Imoto S,Murakami K,Ogawa A,Uchitomi Y

    更新日期：2019-01-01 00:00:00

  • Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer.

    abstract：BACKGROUND:Retrospective evaluation of the effectiveness and adverse events (AEs) of a sequential chemotherapy regimen using gemcitabine + carboplatin (GCarbo) followed by GCarbo + docetaxel (GCarboD) for advanced upper-tract urothelial carcinoma (UTUC). METHODS:We treated 56 patients with advanced UTUC. Mean patient ...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-015-0846-z

    authors： Yoneyama T,Imai A,Hatakeyama S,Hashimoto Y,Koie T,Ohyama C

    更新日期：2015-12-01 00:00:00

  • Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites.

    abstract：BACKGROUND:It is expected that cell-free and concentrated ascites reinfusion therapy (CART) will relieve the symptoms caused by ascites. To date, however, no report of objective changes in patients' symptoms has been published. We have therefore evaluated symptom management by CART. METHODS:From April 2011 to July 201...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-014-0750-y

    authors： Ito T,Hanafusa N,Iwase S,Noiri E,Nangaku M,Nakagawa K,Miyagawa K

    更新日期：2015-06-01 00:00:00

  • Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.

    abstract：BACKGROUND:Neoadjuvant cisplatin-based chemotherapy for patients with muscle-invasive bladder cancer (BC) has better survival benefit than radical cystectomy (RC) alone. However, optimal dosing schedule, including drug selection, number of cycles, and interval between chemotherapy and cystectomy, as well as acceptable ...

    journal_title：International journal of clinical oncology

    pub_type： 临床试验,杂志文章

    doi：10.1007/s10147-012-0447-z

    authors： Koie T,Ohyama C,Hashimoto Y,Hatakeyama S,Yamamoto H,Yoneyama T,Kamimura N

    更新日期：2013-08-01 00:00:00

  • Preoperative hydronephrosis as a predictor of postnephroureterectomy survival in patients with upper tract urothelial carcinoma: a two-center study in Japan.

    abstract：OBJECTIVE:To evaluate the predictive value of preoperative hydronephrosis for pathological outcome and prognosis in patients with upper tract urothelial carcinoma treated with nephroureterectomy. METHODS:167 patients with UTUC treated with nephroureterectomy at our two institutions in Japan between 2002 and 2017 were ...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s10147-019-01535-6

    authors： Fukui T,Kanno T,Kobori G,Moroi S,Yamada H

    更新日期：2020-03-01 00:00:00

  • Four cases of advanced renal cell carcinoma with pancreatic metastasis successfully treated with radiation therapy.

    abstract：:We report four patients with pancreatic metastasis of renal cell carcinoma who were successfully treated with radiation therapy. The patients were one woman and three men with a median age of 55 years (range, 49 to 62 years) who underwent radical nephrectomy for primary renal cell carcinoma. The median interval from n...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-008-0833-8

    authors： Saito J,Yamanaka K,Sato M,Mori N,Sekii K,Yoshioka T,Itatani H,Nakatsuka S

    更新日期：2009-06-01 00:00:00

  • Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review.

    abstract：BACKGROUND:There is no standard chemotherapy available for unresectable or metastatic small bowel adenocarcinoma (SBA) because of its rarity. This systematic review aims to assess the efficacy and safety of chemotherapy for patients with unresectable or metastatic SBA. METHODS:In accordance with the PRISMA statements,...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-020-01703-z

    authors： Nishikawa Y,Hoshino N,Horimatsu T,Funakoshi T,Hida K,Sakai Y,Muto M,Nakayama T

    更新日期：2020-08-01 00:00:00

  • Avascular necrosis of bilateral femoral head as a result of long-term steroid administration for radiation pneumonitis after tangential irradiation of the breast.

    abstract：:We report a patient with avascular necrosis of the bilateral femoral head resulting from long-term steroid administration for radiation pneumonitis that occurred after tangential irradiation of the breast. The patient was a 50-year-old postmenopausal woman with breast cancer, stage IIIB (T4bN0M0) in the right C area. ...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-006-0607-0

    authors： Kosaka Y,Mitsumori M,Araki N,Yamauchi C,Nagata Y,Hiraoka M,Kodama H

    更新日期：2006-12-01 00:00:00

  • Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer.

    abstract：BACKGROUND:Our previous nonrandomized prospective study showed that template-based lymphadenectomy improved survival among patients with renal pelvic cancer but not among patients with ureteral cancer. However, regional node sites vary according to the tumor's location in relation to the ureter. Therefore, this retrosp...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-016-1024-7

    authors： Kondo T,Hara I,Takagi T,Kodama Y,Hashimoto Y,Kobayashi H,Iizuka J,Omae K,Yoshida K,Tanabe K

    更新日期：2017-02-01 00:00:00

  • Factors predicting incisional surgical site infection in patients undergoing open radical cystectomy for bladder cancer.

    abstract：BACKGROUND:The risk factors of incisional surgical site infection (iSSI) after open radical cystectomy (ORC) have not been fully investigated. The aim of the present study is to examine factors correlated with iSSI development after ORC with intestinal urinary diversion. METHODS:A total of 178 patients who had undergo...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-013-0646-2

    authors： Gondo T,Ohno Y,Nakashima J,Hashimoto T,Takizawa I,Tanaka A,Shimodaira K,Satake N,Takeuchi H,Nakagami Y,Ohori M,Tachibana M

    更新日期：2014-10-01 00:00:00

  • Fat replacement of the malignant pancreatic tissue after neoadjuvant therapy.

    abstract：:Pancreatic lipomatosis is characterized as massive lipid infiltration of the pancreatic tissue. Although its etiology is ill defined; obesity, diabetes mellitus, chronic pancreatitis, hereditary pancreatitis, and conditions that cause pancreatic ductal obstruction, for example tumors and stones, are related to its pat...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-009-0001-9

    authors： Makay O,Kazimi M,Aydin U,Nart D,Yilmaz F,Zeytunlu M,Goker E,Coker A

    更新日期：2010-02-01 00:00:00

  • Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.

    abstract：BACKGROUND:Gastric cancer (GC) patients are usually diagnosed in advanced stages which results in high mortality. This study aimed to identify novel circulating miRNAs as biomarkers for the early detection of GC. METHODS:Candidate miRNA was identified after integrated analysis of two Gene Expression Omnibus (GEO) data...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-019-01532-9

    authors： Shi Y,Wang Z,Zhu X,Chen L,Ma Y,Wang J,Yang X,Liu Z

    更新日期：2020-01-01 00:00:00

  • A history of the cancer registration system in Japan.

    abstract：:In Japan, the first actual survey of morbidity from cancer was conducted by Dr. Mitsuo Segi in Miyagi Prefecture from 1951 to 1953. Population-based cancer registries were started in 1957 in Hiroshima and 1958 in Nagasaki for the follow-up of survivors of the atomic bombings. Public population-based cancer registries,...

    journal_title：International journal of clinical oncology

    pub_type： 历史文章,杂志文章

    doi：10.1007/s10147-008-0759-1

    authors： Okamoto N

    更新日期：2008-04-01 00:00:00

  • Multiple lymphomatous polyposis overexpressing cyclin D1.

    abstract：:A case of mantle cell lymphoma (MCL) associated with multiple lymphomatous polyposis (MLP) is reported is a 62-year-old woman, with special reference to the patient's clinical features and response to treatment. There were multiple widespread polypoid lesions in the entire gastrointestinal tract, with ileocecal masses...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s101470050012

    authors： Tsujimura H,Takagi T,Tamaru J,Sakai C

    更新日期：2000-02-01 00:00:00

  • Comparisons of the impact of systematic uncertainties in patient setup and prostate motion on doses to the target among different plans for definitive external-beam radiotherapy for prostate cancer.

    abstract：BACKGROUND:We aimed to compare the impact of systematic uncertainties in patient setup and prostate motion on three different external-beam radiotherapy protocols for prostate cancer. METHODS:To simulate possible near-maximum systematic errors, the isocenter position was shifted to eight points with +/-1.65 SD of the ...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-007-0724-4

    authors： Zhu SY,Mizowaki T,Norihisa Y,Takayama K,Nagata Y,Hiraoka M

    更新日期：2008-02-01 00:00:00

  • Spontaneous regression of hepatocellular carcinoma.

    abstract：:We report four patients with hepatocellular carcinoma (all men, with liver cirrhosis and hepatitis C virus infections) who showed spontaneous regression of the tumor. When the spontaneous regression occurred all of the patients were over age 67 years. They showed a rapid increase of serum alpha-fetoprotein levels just...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-006-0591-4

    authors： Kondo S,Okusaka T,Ueno H,Ikeda M,Morizane C

    更新日期：2006-10-01 00:00:00

  • Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma.

    abstract：PURPOSE:The purpose of this study was to determine if quantitative SUV-related, volumetric FDG PET parameters, and texture features (SPs, VPs, and TFs, respectively) were useful to evaluate and predict response and recurrence after chemotherapy in follicular lymphoma (FL). METHODS:Pre- and posttreatment FDG PET examin...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-019-01482-2

    authors： Tatsumi M,Isohashi K,Matsunaga K,Watabe T,Kato H,Kanakura Y,Hatazawa J

    更新日期：2019-10-01 00:00:00

  • Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.

    abstract：BACKGROUND:Although regorafenib or trifluridine/tipiracil (FTD/TPI) has been recognized as a later-line standard treatment in patients with metastatic colorectal cancer (mCRC), not all patients have beneficial outcomes. This study aimed to develop a prognostic scoring system for evaluating the overall survival (OS) ben...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s10147-019-01600-0

    authors： Moriwaki T,Fukuoka S,Masuishi T,Takashima A,Kumekawa Y,Kajiwara T,Yamazaki K,Esaki T,Makiyama A,Denda T,Hatachi Y,Suto T,Sugimoto N,Enomoto M,Ishikawa T,Kashiwada T,Oki E,Komatsu Y,Tsuji A,Tsuchihashi K,Sakai D,

    更新日期：2020-04-01 00:00:00

  • Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma.

    abstract：BACKGROUND:Increase of the Ca2+-activated chloride channel TMEM16A is contribute to tumorigenesis. However, the expression level of TMEM16A and its underlying molecular mechanism for TMEM16Apromotingliver carcinogenesis is remains unknown. METHODS:In the present study, the expression of TMEM16A in hepatocellular carci...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-020-01653-6

    authors： Zhang C,Liu J,Han Z,Cui X,Peng D,Xing Y

    更新日期：2020-06-01 00:00:00

  • Gastrectomy for invasive micropapillary carcinoma is associated with poorer disease-free and disease-specific survival.

    abstract：BACKGROUND:Invasive micropapillary carcinoma (IMPC) is a relatively rare subtype of gastric adenocarcinoma and has aggressive histopathologic characteristics, including lymphatic and vascular invasion. However, the associated long-term survival outcomes remain unclear. This study aimed to compare the clinicopathologica...

    journal_title：International journal of clinical oncology

    pub_type： 杂志文章

    doi：10.1007/s10147-019-01514-x

    authors： Kano M,Hihara J,Kaneko M,Uemura K,Ohge H,Sueda T

    更新日期：2019-12-01 00:00:00